Sheila Shahidzadeh Sears, PhD

Sheila Shahidzadeh Sears, PhD has a diverse range of work experience in various roles and organizations. Most recently, they worked at Encoded Therapeutics Inc. as a Senior Scientist I, starting in March 2022. Prior to this role, they were an Associate Study Director at the same company, starting in June 2021.

Before joining Encoded Therapeutics Inc., Sheila worked as a Scientist II at Charles River Laboratories from May 2020 to June 2021. Sheila then transitioned to a position as a Postdoctoral Scholar at the University of California, San Francisco, where they worked from January 2019 to May 2020.

Sheila's academic experience includes their time as a PhD Candidate at Syracuse University from August 2013 to December 2018. Sheila'sdissertation focused on the regulation of in vivo excitatory/inhibitory balance in the cystine/glutamate exchanger system xc-. Sheila utilized two epilepsy models to study this balance and explored neuroanatomy at various levels through staining techniques.

During their undergraduate years at UC Santa Barbara, they gained research experience in two different projects. The first project involved investigating astrocyte morphological changes in response to a mouse model of retinal degeneration, while the second project focused on neuroendocrine mechanisms involved in social interactions.

Overall, Sheila Shahidzadeh Sears, PhD has built a strong foundation of experience in research and scientific roles, spanning both industry and academia.

Sheila Shahidzadeh Sears, PhD, holds a Bachelor of Science (B.S.) degree in Biopsychology, with a minor in French, from UC Santa Barbara. Sheila attended the university from 2008 to 2012. Subsequently, Sheila pursued their academic career at Syracuse University, where they obtained a Doctor of Philosophy (PhD) in Biology with a specialization in Neuroscience. Sheila completed their doctoral studies at Syracuse University between 2013 and 2018.